Labshake search
Citations for Stemcell Technologies :
651 - 700 of 1145 citations for Erythromycin 90 95% Erythromycin A N N Dimethyl 13C2 ~90% 100 Ug Ml In Mtbe since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2024Quote: ... was dispensed to a 50 mL SepMate™ (#85450, Stemcell Technologies,) tube ...
-
bioRxiv - Cell Biology 2023Quote: ... Heparin 4 µg/mL (Ref 07980, Stemcell technologies, Saint Égrève, France) and Hydrocortisone 480 ng/mL (Ref 07925 ...
-
bioRxiv - Immunology 2022Quote: ... T cells were polyclonally activated using ImmunoCult Human CD3/CD2/CD28 T Cell Activator (1:100) (Stemcell Technologies).
-
bioRxiv - Immunology 2022Quote: ... T cells were polyclonally activated using ImmunoCult Human CD3/CD2/CD28 T Cell Activator (1:100) (Stemcell Technologies). Before activation and at different time points thereafter ...
-
bioRxiv - Cell Biology 2023Quote: ... organoids were removed from matrix by incubation with ice-cold Gentle Cell Dissociation Reagent (STEMCELL Technologies, 100-0485) with gentle rocking at 4°C for 60 minutes ...
-
bioRxiv - Cell Biology 2023Quote: ... sorted cell populations were seeded (100 or 250 cells/well) into 6 well SmartDish™ (Stem Cell Technologies). After incubation for 14 days ...
-
bioRxiv - Bioengineering 2023Quote: ... the coating material was removed by introducing 100 μl of PneumaCult™-ALI Medium (05001, Stemcell Technologies, Canada) without DAPT into the top channel ...
-
bioRxiv - Cell Biology 2024Quote: ... Splenocytes were dissociated from the tissue matrix by gentle compression through a 100 μm strainer (StemCell Technologies, 27217). RBC lysis (Biolegend ...
-
bioRxiv - Neuroscience 2024Quote: ... hESCs were fed every two days and split every 4–7 days using ReLeSR (StemCell Technologies, 100-0483) according to the manufacturer’s instructions ...
-
bioRxiv - Cancer Biology 2024Quote: ... 3D organoids were harvested from the basement membrane matrix using Gentle Cell Dissociation Reagent (100-0485, StemCell Technologies), fixed with 4% paraformaldehyde ...
-
bioRxiv - Genetics 2023Quote: ... cells were plated into stem cell media without penicillin-streptomycin supplemented with CloneR2 (STEMCELL Technologies; cat. no. 100-0691) and 10 μM ROCK inhibitor ...
-
bioRxiv - Neuroscience 2023Quote: ... Samples were then incubated with CD45-APC (1 µl per 50,000 cells in 100 µL, STEMCELL Technologies Catalog #60018AZ) and CD11B-FITC (1 µl per 50,000 cells in 100 µL ...
-
bioRxiv - Genetics 2023Quote: ... and fed every other day with stem cell media: mTeSR Plus with supplement (STEMCELL Technologies; cat. no. 100-0276) and 0.5% penicillin-streptomycin (ThermoFisher ...
-
bioRxiv - Genetics 2023Quote: ... The medium was changed every day and cells were passaged when 70% confluent using ReleSR (STEMCELL Technologies, #100-0484) at a 1:20 ratio ...
-
bioRxiv - Genetics 2023Quote: ... and fed every other day with stem cell media: mTeSR Plus with supplement (STEMCELL Technologies; cat. no. 100-0276) and 0.5% penicillin-streptomycin (ThermoFisher ...
-
bioRxiv - Developmental Biology 2024Quote: ... resuspended in 100 μL phosphate buffered saline (PBS) without Ca2+ and Mg2+ (D-PBS; Stem Cell Technologies, cat.# 37350) and 20 μL aliquots were prepared and stored at -80°C.
-
bioRxiv - Systems Biology 2020Quote: ... followed by trituration in 5 U/mL dispase (Stem Cell Technologies 07913) plus 1 mg/mL DNase I (Stem Cell Technologies 07900 ...
-
bioRxiv - Biochemistry 2020Quote: ... released from the plates using 1 mL of ReLeSR® (Stemcell Technologies), and resuspended by mechanical agitation ...
-
bioRxiv - Bioengineering 2021Quote: ... iPSCs were thawed in 1 ml of mTeSR medium (Stem Cell Technologies) with the addition of 10 μM Rho kinase inhibitor (ROCKi ...
-
bioRxiv - Bioengineering 2021Quote: ... 1 ng/mL human recombinant Leukemia Inhibitory Factor (LIF, STEMCELL Technologies, 78055.1) and 10 ng/mL human recombinant Epidermal Growth Factor (EGF ...
-
bioRxiv - Bioengineering 2021Quote: ... 1 ng/mL human recombinant Leukemia Inhibitory Factor (LIF, STEMCELL Technologies, 78055.1) and 10 ng/mL human recombinant Epidermal Growth Factor (EGF ...
-
bioRxiv - Bioengineering 2021Quote: ... 10 ng/mL human recombinant Leukemia Inhibitory Factor (LIF, STEMCELL Technologies, 78055.1), and 10 ng/mL GDNF ...
-
bioRxiv - Bioengineering 2021Quote: ... 20 ng/mL human recombinant Epidermal Growth Factor (EGF, STEMCELL Technologies, 78006.1), 10 ng/mL human recombinant Leukemia Inhibitory Factor (LIF ...
-
bioRxiv - Neuroscience 2021Quote: ... TNF alpha (0.5ng/mL final concentration in PBS, human recombinant, Stemcell Tech) was added to half of the wells ...
-
bioRxiv - Cancer Biology 2021Quote: ... Transduced GBM-DCs were treated with doxycycline 2μg/ml (#72742, STEMCELL Technologies) to induce OKMS expression until ic-GSC colonies appeared after four weeks ...
-
bioRxiv - Cancer Biology 2021Quote: ... 0.5 μg/ml hydrocortisone and 10% Mammocult Proliferation Supplement (Stem Cell Technology). After 6-7 days ...
-
bioRxiv - Immunology 2021Quote: ... counted and treated with 10 U ml−1 DNAse I (Stemcell Technologies, #) for 15 min at RT in order to prevent cell clumping ...
-
bioRxiv - Synthetic Biology 2021Quote: ... and 20 ng/ml human recombinant bFGF (Stem Cell Technologies cat# 78003). For 10 gBlocks pool ...
-
bioRxiv - Cancer Biology 2022Quote: ... 5 ml of mouse Neurocult Proliferation Supplement (Stem Cell Technologies, Catalog# 05701), 50 μL of 20 μg/ml EGF (Peprotech Inc ...
-
bioRxiv - Cancer Biology 2022Quote: ... organoid medium supplemented with 50 ng/ml hEGF (Stem Cell Technologies, 78006.2), 500 ng/ml hR-Spondin1 (R&D systems ...
-
bioRxiv - Immunology 2022Quote: ... The blood was treated with 2.5 μl/ml Rosettesep B (Stemcell technologies) for 20 mins at room temperature.
-
bioRxiv - Immunology 2020Quote: ... and 5 ng/mL recombinant human IL-15 (StemCell Technologies, Cat # 78031). Recombinant SARS-CoV-2 receptor binding domain was coated onto MaxiSorp 96-well plates (Thermo Scientific ...
-
bioRxiv - Immunology 2020Quote: ... counted and treated with 10 U ml−1 DNAse I (Stemcell Technologies, #) for 15 min at RT in order to prevent cell clumping ...
-
bioRxiv - Cancer Biology 2021Quote: ... washed and seeded into 1.5 mL of Methocult H4230 (Stem Cell Technologies) supplemented with 50ng/ml human SCF ...
-
bioRxiv - Cancer Biology 2020Quote: ... Cells were plated at 200,000 cells/ml Stem Span medium (StemCell Technologies) supplemented with 3GT cytokines (20ng/ml IL-3 ...
-
bioRxiv - Immunology 2021Quote: ... and human BAFF(71) in 80 mL StemCell medium A (StemCell Technologies) containing 6.3 µg/mL of CpG (phosphorothioate-modified oligodeoxynucleotide ZOEZOEZZZZZOEEZOEZZZT ...
-
bioRxiv - Neuroscience 2022Quote: ... Heparin solution 2 μg/ml (cat# 07980, Stem Cell Technologies, Vancouver, Canada), EGF 20 ng/ml (Cat#315-09 ...
-
bioRxiv - Cancer Biology 2022Quote: ... 10 ng/ml human recombinant basic fibroblast growth factor (STEMCELL Technologies, 78003.1), and 0.679 U/ml heparin (Sigma ...
-
bioRxiv - Developmental Biology 2022Quote: ... and supplemented with BDNF (20 ng/ml, Stemcell technologies, cat. no. 78005.3), GDNF (20 mg/ml ...
-
bioRxiv - Microbiology 2022Quote: ... PneumaCult ALI medium supplemented with 4 μg/mL heparin (Stem Cell Technologies), 5 μM hydrocortisone ...
-
bioRxiv - Microbiology 2023Quote: ... supplemented with Hydrocortisone stock solution (5 μl/ml; Stem cell technologies #07925) and Heparin solution (2 μl/ml ...
-
bioRxiv - Cancer Biology 2023Quote: PDECs were treated with 25ul/mL anti-CD3/CD28/CD2 (Stemcell Technologies), 100ug/mL Atezolizumab (Selleck Chemicals) ...
-
bioRxiv - Genomics 2022Quote: ... 4 mL of 29% Iodoxanol cushion was prepared with OptiPrep (Stemcell Technologies) and diluent medium (250 mM sucrose ...
-
bioRxiv - Neuroscience 2023Quote: ... 20 ng/mL brain-derived neurotropic factor (BDNF; Cat# 78005, STEMCELL Technologies), 20 ng/mL glial cell-derived neurotropic factor (GDNF ...
-
bioRxiv - Cancer Biology 2023Quote: ... and fed IL-2 (50 U/mL; Stem Cell Technologies, Vancouver, Canada) every 48 hours ...
-
bioRxiv - Biochemistry 2023Quote: ... cells were further dissociated in Dispase 5 U/mL (STEMCELL Technologies, 07913) plus 50 µg/mL DNase I (Sigma ...
-
bioRxiv - Molecular Biology 2023Quote: ... supplemented with 20 ng/ml recombinant human EGF (STEMCELL Technologies, cat# 78006). For passaging ...
-
Self-organization of embryonic stem cells into a reproducible embryo model through epigenome editingbioRxiv - Developmental Biology 2024Quote: ... followed by adding 0.5 ml of anti-adherence solution (Stemcell Technologies, 07010). Plates were centrifuged 5 minutes at 1,000 rcf and incubated 20 minutes at room temperature ...
-
bioRxiv - Cell Biology 2023Quote: ... and Hydrocortisone 480 ng/mL (Ref 07925, Stemcell technologies, Saint Égrève, France). Differentiation was monitored daily and differentiation medium was carefully changed every 2 days for 21 days ...
-
bioRxiv - Immunology 2021Quote: ... Cells were cultured in 100-200 μl of Iscove’s Modified Eagle Medium (IMDM) supplemented with 20% serum substitute (BIT 9500; Stemcell Technologies), 1 μg/ml low-density lipoprotein (LDL ...